Clinical Trial

Energetics and Glutamate in Schizophrenia

Study acronym: EAGLES
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this case-control study is to compare brain glutamate, glucose utilisation, lactate production and brain activity in healthy volunteers and people with a diagnosis of schizophrenia. It investigates the following main questions: Whether, compared to healthy volunteers, participants with schizophrenia show: 1. reduction in brain glucose utilisation 2. increased brain lactate 3. greater variability in brain glutamate Participants will be asked to have a screening visit, a MRI brain scan and a PET-MRI brain scan.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-31; most recent amendment 2025-08-28.
Status change: Not Yet Recruiting → Recruiting 2024-02-22
Trial Details
NCT Number NCT06236048
Lead Sponsor King's College London
Conditions Schizophrenia
Enrollment 75 participants
Start Date 2024-03-04
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-05